Cytek Biosciences Announces $50 Million Stock Repurchase Program
June 06, 2024 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the...
Netcompany - Transactions in connection with share buyback programme
June 06, 2024 07:12 ET
|
Netcompany Group A/S
Company announcement No. 24/2024 6 June 2024 On 3 May 2024, Netcompany Group A/S (“Netcompany”) announced that a share buyback programme of up to...
Cartesian Therapeutics Announces New Employment Inducement Grant
June 06, 2024 07:05 ET
|
Cartesian Therapeutics, Inc.
GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the...
Share Buyback Transaction Details May 30 – June 5, 2024
June 06, 2024 04:00 ET
|
Wolters Kluwer N.V.
PRESS RELEASE Share Buyback Transaction Details May 30 – June 5, 2024 Alphen aan den Rijn – June 6, 2024 - Wolters Kluwer (Euronext: WKL), a global leader in...
Park Street A/S - Share buyback program 2024
June 06, 2024 03:02 ET
|
Park Street A/S
Park Street A/S – Share buyback program 2024 Transactions during 27 May 2024 - 06 June 2024 On 28th February 2024, Park Street A/S announced a share buy-back program, as described in Company...
Transaction in own shares
June 06, 2024 02:00 ET
|
OSB GROUP PLC
OSB GROUP PLC ISIN: GB00BLDRH36006 June 2024 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares The Company announces...
Annexon Announces Pricing of $125 Million Underwritten Public Offering
June 05, 2024 23:04 ET
|
Annexon Biosciences
BRISBANE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with...
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives
June 05, 2024 18:19 ET
|
Mushrooms Inc.
ESTERO, Fla., June 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Mushrooms Inc. (OTC: MSRM), a leading innovator in biotechnology and sustainable healthcare solutions using mushrooms and mycelium, is...
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 05, 2024 17:46 ET
|
Bio-Path Holdings, Inc.
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and...
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
June 05, 2024 17:07 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...